Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With Itch

NCT03673059 · View on ClinicalTrials.gov ↗

Study Summary

This was a multi-center, 14-day clinical use study with a 7-day regression period, being conducted to assess the changes in the skin microbiome with two moisturizers in female and male subjects 16-50 years of age with mild to moderate eczema that experienced a recent itch flare up.

Conditions Studied

Interventions

  • DRUG OTC Eczema Moisturizer Regimen
  • OTHER Cosmetic Moisturizer Regimen

Study Locations (2)

Colorado

  • Thomas J. Stephens & Associates, Inc. — Colorado Springs

Texas

  • Thomas J. Stephens and Associates, Inc. — Richardson

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2015-03-27
Est. Completion 2016-06-13
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03673059

The ClinicalTrials.gov registry entry for NCT03673059 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Microbiota appearing as the primary indexed condition, and to 2 interventions — of which OTC Eczema Moisturizer Regimen is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT03673059 reports 2 study locations spanning 2 distinct geographic areas — top geographies include Colorado, Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT03673059 about?

NCT03673059 is a clinical study titled "Clinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With Itch". This was a multi-center, 14-day clinical use study with a 7-day regression period, being conducted to assess the changes in the skin microbiome with two moisturizers in female and male subjects 16-50 years of age with mild to moderate eczema that experienced a recent itch flare up.

What is the current status of trial NCT03673059?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2015-03-27. Estimated completion is 2016-06-13.

What conditions does trial NCT03673059 study?

This clinical trial studies the following conditions: Microbiota. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT03673059?

The interventions under investigation include: OTC Eczema Moisturizer Regimen (DRUG), Cosmetic Moisturizer Regimen (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT03673059?

This trial is sponsored by Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT03673059 being conducted?

This trial has 2 study locations across Colorado, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial